Alessandro Feo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Hippocampal glial alterations are associated with Lamin B1 dysregulation and abnormal nuclear morphology in a rat model of fragile X syndrome.
Journal: Neurobiology of disease
Published: November 24, 2025
Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: September 16, 2025
Role of peroxisome proliferator-activated receptors α and γ in mediating the beneficial effects of β-caryophyllene in a rat model of fragile X syndrome.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: September 16, 2024
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors.
Journal: Pharmacological research
Published: November 13, 2023
Correction to: Group I and group II metabotropic glutamate receptors are upregulated in the synapses of infant rats prenatally exposed to valproic acid.
Journal: Psychopharmacology
Published: November 09, 2023
Group I and group II metabotropic glutamate receptors are upregulated in the synapses of infant rats prenatally exposed to valproic acid.
Journal: Psychopharmacology
Published: August 01, 2023
Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.
Journal: Psychopharmacology
Published: September 05, 2022
Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: May 03, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026